Funda Obuz

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study

Aggregation‐induced emission luminogens for in vivo molecular imaging and theranostics in cancer

Reconsideration of Clinicopathologic Prognostic Factors in Pancreatic Neuroendocrine Tumors for Better Determination of Adverse Prognosis

Efficacy of High Resolution Magnetic Resonance Imaging in Preoperative Local Staging of Rectal Cancer